Fortis Healthcare Ltd (FORTIS) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Fortis Healthcare demonstrated healthy improvement in Q3 FY25 and 9M FY25, driven by strong hospital business performance.
- Consolidated revenue reached INR 1,928 crores in Q3, a 14.8% YoY growth, with hospital revenues growing by 16.8% to INR 1,623 crores.
- Consolidated operating EBITDA increased 32% to INR 375 crores, with a margin of 19.4% compared to 16.9% in Q3 FY24.
- Hospital business now contributes 84% of consolidated revenue and 87% of operating EBITDA.
- Eleven facilities achieved operating EBITDA margins above 20%, contributing 74% to hospital revenue in Q3.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.